April 2023 Pharmacy Updates
Date: 04/07/23
Important Update - All Stimulant Claims Require an ADHD Diagnosis for Members 18 Years of Age and Older
Effective April 1, 2023, a prior authorization will be required for members 18 years and older for short and long-acting stimulants unless the member has a diagnosis of ADHD. If member has an ADHD diagnosis, please indicate on the prescription.
Effective March 31, 2023, the following medications will no longer be preferred.
Effective Date | Drug Name | Potential Alternatives |
|---|---|---|
| 03/31/2023 | Lantus (Brand) | Insulin Glargine (Generic for Lantus) or Levemir |
| 03/31/2023 | Lantus Solostar (Brand) | Insulin Glargine Solostar (Generic for Lantus Solostar), Levemir Flextouch Solution Pen-Injector, or Levemir Flexpen |
| 03/31/2023 | Basaglar Kwikpen (Brand) and Basaglar Tempo Pen | Insulin Glargine Solution Pen-Injector (Generic for Basaglar Kwikpen), Levemir Flextouch Solution Pen-Injector, or Levemir Flexpen |